- 2023 CPG –Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update (open access at Pediatric Blood and Cancer)
- Endorsed by the Children’s Oncology Group (COG) and the Multinational Association of Supportive Care in Cancer (MASCC)
- Archived 2016 CPG – Guideline for the treatment of breakthrough and the prevention of refractory chemotherapy‐induced nausea and vomiting in children with cancer (open access at Pediatric Blood and Cancer)
- Endorsed by the Children’s Oncology Group (COG)
If you have any questions about any of the POGO guidelines, our development processes or guidelines under development, please email:
Paula Robinson, MD, MSc
Senior Manager, Supportive Care and Guidelines